• Info
  • Insider Ownership

Insider Trading & Ownership of Gwenn Hansen

Location
San Francisco, CA
Summary
The estimated net worth of Gwenn Hansen is at least $799,068 dollars as of 10 Feb 2026. Gwenn Hansen is the Chief Scientific Officer of Nurix Therapeutics, Inc. and owns shares of Nurix Therapeutics, Inc. (NRIX) stock worth about $799.1K.
Signature
/s/ Daniel Burbach, as Attorney-in-Fact for Gwenn Hansen
All Insider Reports
All Insider Reports

Notify me when Gwenn Hansen files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Gwenn Hansen

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
NRIX Nurix Therapeutics, Inc. Chief Scientific Officer $799,068 -$224,134 -22% 10 Feb 2026

Insider Transactions Reported by Gwenn Hansen:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.